A Randomised Trial of Adriamycin and Taxotere vs. Adriamycin and Cyclophosphamide in Breast Cancer

Completed

• Conditions: Cancer; Breast cancer; Malignant neoplasm of breast

• Registration Number: ISRCTN15113276
• Lead Sponsor: Scottish Cancer Therapy Network (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2002-08-19
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 363

Inclusion Criteria

1. Histologically proven breast cancer (BrCa)
2. Potentially operable disease >3cm diameter, locally advanced disease (including T4 lesions) or inflammatory BrCa
3. Patients older then 18 years

Exclusion Criteria

Does not match inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Added 12/02/10: <br>Overall (complete and partial) clinical response rates

Secondary Outcome Measures

Name	Time	Method
Added 12/02/10: <br>Number of relapses